What is the LGND stock price prediction for next 2 weeks?

According to our price prediction algorithm,Ligand Pharmaceuticals Incorporated (LGND) price will be around $281.50 in the next 2 weeks. This means it will decrease by -2.843480361703594 from the last closing price. This prediction may vary from other time period filters for LGND stock.

What can be the highest Possible price of LGND stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, LGND can achieve the highest price of $286.38 which is -1.1579948804908207 lower than last closing price. This prediction may vary from other time period filters for LGND stock.

What can be the lowest Possible price of LGND stock in next 2 weeks?

As per the forecast and algorithmic analysis, LGND stock price can be as low as $276.69 which is -4.503135762294722 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for LGND stock.

Will LGND stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that LGND stock will lose-2.843480361703594 in the next 2 weeks. This prediction may vary from other time period filters for LGND stock.

What is LGND stock last closing price?

Last closing price of LGND stock was $285.60.

What is LGND stock price prediction?

LGND stock price prediction means predicting the future closing prices of LGND stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of LGND stock in a certain time period.

How we predict LGND stock future prices?

If you are searching for LGND stock forecast, analysis or price prediction, then you might be wondering what Ligand Pharmaceuticals Incorporated (LGND) will do in the future. Our LGND price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This LGND price prediction will likely answer most of your questions.

How frequent we update LGND stock predictions?

We are updating the forecasts for the LGND stock on daily basis.

Is using ML forecasting for LGND stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for LGND stock same for all the time periods?

No, the prediction for LGND stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Ligand Pharmaceuticals Incorporated Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$285.60-0.24%Since 2 Weeks

Predicted Price$281.50-2.84%For 2 Weeks

Upper Predicted Price$286.38-1.16%For 2 Weeks

Lower Predicted Price$276.69-4.5%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of LGND will decline by -2.84% over the next 2 Weeks and hit $281.50 by Thursday, September 17, 2026. In that time frame, LGND's share price is expected to range between $276.69 and $286.38.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Sep 17, 2026	276.69	281.50	286.38
Sep 16, 2026	277.44	282.17	286.82
Sep 15, 2026	276.66	281.75	286.37
Sep 14, 2026	275.29	280.41	285.38
Sep 11, 2026	276.93	282.01	286.82
Sep 10, 2026	279.77	284.75	289.54
Sep 9, 2026	280.20	285.42	290.71
Sep 8, 2026	280.02	285.00	290.03
Sep 7, 2026	278.46	283.65	288.36
Sep 4, 2026	280.42	285.26	289.96

LGND shares fell -1.43% in Friday, September 4, 2026's trading session, dropping from a previous close of $289.74 to move at $285.60. The stock demonstrated notable intraday movement (see LGND's key stats for a full breakdown), fluctuating between $285.44 and $289.72, a +1.50% trading range. While recent weeks have seen some volatility, LGND has managed to secure a +1.93% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 132.39K shares changing hands, 57.9K fewer than the previous session. This amounted to $37.81M in total market activity.

Will LGND Continue Its Upward Trend?

According to analyst ratings and projections for LGND, Ligand Pharmaceuticals Incorporated shares are anticipated to increase by +0.27%, potentially reaching $286.38 per share by September 17, 2026. Short-term technical indicators currently suggest a neutral sentiment for LGND. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the LGND stock forecast, now is a good time to buy LGND stock because its current trading price is +1.46% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on LGND covering social and institutional perspectives.

LGND Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into LGND's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 47.00% to 48.76%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 53.78%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 55.58%, maintains a neutral outlook for the long term. Insights into LGND's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Ligand Pharmaceuticals Short-Term Forecasts

LGND Forecast For Next 5 Days

Our algorithm anticipates Ligand Pharmaceuticals (LGND) stock could hit $286.54 by Sep 11, 2026. This represents a +0.33% fall from today's price, following a -4.96% change over the past five days.

LGND Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Ligand Pharmaceuticals Incorporated (LGND) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $281.23, which would mean a -1.53% decrease from the current price of $285.60. Projections for this period range from a high of $320.81 to a low of $243.80.

LGND Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Ligand Pharmaceuticals's price over the next three months point to a rise. LGND stock is expected to peak at $334.45 on Nov 11, 2026 after potentially dipping to $275.25 on Sep 04, 2026. On average, LGND is likely to trade around $302.05 in the coming 90 days.

Ligand Pharmaceuticals Stock Forecast 2025

Based on our predictive models, Ligand Pharmaceuticals (LGND) is expected to trade between $275.25 and $334.45 throughout 2026. This would result in an average price of $305.56, potentially offering investors a +6.99% return from current levels.

Ligand Pharmaceuticals Incorporated Monthly Forecast 2026–2027

September 2026

According to our latest forecast models, Ligand Pharmaceuticals Incorporated (LGND) is positioned to show a strong performance in September 2026. The price is predicted to move between $275.25 and $308.45, settling at an average of $292.46. This could translate to a +2.40% gain.

October 2026

Based on current market signals, Ligand Pharmaceuticals Incorporated is projected to trend october 2026. We forecast a trading range from $285.29 to $313.84, with a likely average price of $299.06. Investors could expect a potential return of +4.71%.

November 2026

Our predictive algorithms indicate Ligand Pharmaceuticals Incorporated stock may see a shift in November 2026. The expected range spans $293.75–$334.45, with an average target of $311.22. This represents a positive outlook and a possible gain of +8.97%.

December 2026

Analyzing established trends, Ligand Pharmaceuticals Incorporated looks set to move in December 2026. Projections place the stock between $304.41 and $332.40, averaging around $317.44. This suggests a +11.15% gain from current levels.

January 2027

Market indicators suggest Ligand Pharmaceuticals Incorporated could experience notable changes during January 2027. Prices could fluctuate within $305.84 to $332.86, with a midpoint forecast of $319.69. The stock might deliver a +11.94% gain.

February 2027

Forecasting for February 2027, models estimate that Ligand Pharmaceuticals Incorporated may undergo key fluctuations. If trends hold, the stock might trade between $304.09 and $334.56, averaging $319.36. This signals a positive trajectory with potential returns around +11.82%.

March 2027

According to our latest forecast models, Ligand Pharmaceuticals Incorporated (LGND) is positioned to show a strong performance in March 2027. The price is predicted to move between $313.64 and $342.03, settling at an average of $326.50. This could translate to a +14.32% gain.

April 2027

Based on current market signals, Ligand Pharmaceuticals Incorporated is projected to trend april 2027. We forecast a trading range from $321.30 to $354.69, with a likely average price of $338.43. Investors could expect a potential return of +18.50%.

May 2027

Our predictive algorithms indicate Ligand Pharmaceuticals Incorporated stock may see a shift in May 2027. The expected range spans $332.13–$358.36, with an average target of $344.79. This represents a positive outlook and a possible gain of +20.72%.

June 2027

Analyzing established trends, Ligand Pharmaceuticals Incorporated looks set to move in June 2027. Projections place the stock between $330.97 and $361.22, averaging around $346.71. This suggests a +21.40% gain from current levels.

July 2027

Market indicators suggest Ligand Pharmaceuticals Incorporated could experience notable changes during July 2027. Prices could fluctuate within $330.46 to $363.57, with a midpoint forecast of $347.49. The stock might deliver a +21.67% gain.

August 2027

Forecasting for August 2027, models estimate that Ligand Pharmaceuticals Incorporated may undergo key fluctuations. If trends hold, the stock might trade between $340.78 and $370.36, averaging $354.38. This signals a positive trajectory with potential returns around +24.08%.

September 2027

According to our latest forecast models, Ligand Pharmaceuticals Incorporated (LGND) is positioned to show a strong performance in September 2027. The price is predicted to move between $350.96 and $372.93, settling at an average of $361.25. This could translate to a +26.49% gain.

LGND's history of dividends and stock splits also plays a role in long-term investor confidence.